Article
C16 peptide and angiopoietin-1 protect against LPS-induced BV-2 microglial cell inflammation.
Life sciences - 1 Sept 2020
Fu Xiaoxiao, Chen Haohao, Han Shu
Abstract excerpt
AIMS: Pathological alterations in the brain can cause microglial activation (MA). Thus, inhibiting MA could provide a new approach for treating neurodegenerative disorders. MAIN METHODS: To investigate the effect of C16 peptide and angiopoietin-1 (Ang1) on inflammation following MA, we stimulated microglial BV-2 cells with lipopolysaccharide (LPS) and used dexmedetomidine (DEX) as a positive control. Specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
